References
- Davies D. A.L., Manstone A. J., Viza D. C., Colombani J., Dausset J. Transplantation 1968; 6: 571
- Kahan B. D., Reisfeld R. A. Science 1969; 164: 514
- Mann D. L., Rogentine G. N., Fahey J. L., Nathenson S. J. Immunol. 1969; 103: 282
- Reisfeld R. A., Pellegrino M. A., Kahan B. D. Science 1971; 172: 1134
- Etheredge E. E., Najarian J. S. Transplant. Proc. 1971; 3: 224
- Russell P. S. Transplant. Proc. 1971; 3: 960
- Buckner D., Graw R. G., Jr., Eisel R. J., Henderson E. S., Perry S. Blood 1969; 33: 353
- Boyum A. Scand. J. Clin. Lab. Invest. 1968; 21: 97, Suppl
- Etheredge E. E., Franecki B. H., Najarion J. S. Tissue Antigens 1971; 1: 109
- , Since alloantisera may differ considerably in cytotoxic potency, it is necessary to employ these reagents at standard titer dilutions, in this case the highest dilution that causes 100 per cent target cell death; also, the next highest dilution (causing 50–75 per cent cell death) is used in parallel testing.
- Sanderson A. R., Batchelor J. R. Nature 1968; 219: 184